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Summary
 
The respective production of specific immunoglobulin (Ig)G2a or IgG1 within 5 d of primary
immunization with Swiss type mouse mammary tumor virus [MMTV(SW)] or haptenated
protein provides a model for the development of T helper 1 (Th1) and Th2 responses. The an-
tibody-producing cells arise from cognate T cell B cell interaction, revealed by the respective
induction of C
 
g
 
2a and C
 
g
 
1 switch transcript production, on the third day after immunization.
T cell proliferation and upregulation of mRNA for interferon 
 
g
 
 in response to MMTV(SW)
and interleukin 4 in response to haptenated protein also starts during this day. It follows that
there is minimal delay in these responses between T cell priming and the onset of cognate in-
teraction between T and B cells leading to class switching and exponential growth. The Th1 or
Th2 profile is at least partially established at the time of the first cognate T cell interaction with
B cells in the T zone.
The addition of killed 
 
Bordetella pertussis
 
 to the hapten–protein induces nonhapten-specific
IgG2a and IgG1 plasma cells, whereas the anti-hapten response continues to be IgG1 domi-
nated. This indicates that a Th2 response to hapten–protein can proceed in a node where there
is substantial Th1 activity.
A
 
fter infection with pathogens such as 
 
Leishmania, Liste-
ria
 
, mycobacteria, or helminths, the T cell response is
strongly polarized into either Th1 or Th2 type cytokine se-
cretion; in other responses, however, T cells producing
mixed patterns of cytokines are observed (for review see
references 1–4). In mice, IFN-
 
g
 
 and IL-4 are characteristic
of secretions in Th1 and Th2 responses, respectively (5).
IL-4 classically induces sequential switching to IgG1 and
then to IgE (6–8), whereas IFN-
 
g
 
 is associated with
switching to IgG2a (9). The relative amounts of the differ-
ent antibody isotypes is governed by signals that control Ig
class switch recombination (10, 11). During T cell–depen-
dent antibody responses, switching is heavily dependent
upon CD40 ligation (12–15). Although sustained CD40
ligation in vitro has been reported to induce class switching
by itself (16), cytokines influence extent of switching and
the class of antibody produced (5–9).
Ig isotype switching is heralded by the production of
switch (germline) transcripts of the C
 
H
 
 region. These start
from an I exon upstream of the appropriate switch region
and proceed into the constant region (for review see refer-
ence 17). It has been shown that expression of switch tran-
scripts in vivo is essential for Ig class switching (18–22),
although this is not necessarily sufficient (23).
In a previous study the sites of immunoglobulin class
switching were assessed during secondary immune re-
sponses to hapten–protein conjugates in the spleen (24).
Within 12 h of secondary challenge, antigen-specific mem-
ory B cells migrate to the T zones, interact with memory T
cells, and start to produce C
 
g
 
1 switch transcript. Although
these transcripts have also been shown to be produced dur-
ing the germinal center reaction (25), our studies indicate
that the amount of C
 
g
 
1 switch transcript recovered per an-
tigen-specific germinal center B cell is 
 
,
 
1% of that during
the cognate interaction between T and B cells in the T
zone (24).
Recently, we have described the primary lymph node
response of BALB/c mice to footpad injection with either
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haptenated protein (4-hydroxy-3-nitrophenyl)acetyl chicken
 
g
 
 globulin (NP-CGG)
 
1
 
 or Swiss type mouse mammary tu-
mor virus [MMTV(SW)] (26). MMTV(SW) induces both
a polyclonal and envelope-specific superantigen-dependent
antibody response (27, for review see reference 28). Super-
antigen-specific T cells start to show signs of activation
within 65 h of virus injection (29). T cell proliferation also
starts on the third day after immunization in the response to
NP-CGG; in both responses this proliferation occurs first
in association with interdigitating dendritic cells. This is
followed, with minimal delay, by cognate interaction of T
cells with B cells and subsequent exponential growth of B
cells in the medullary cords (26). Ig class switching in the
MMTV(SW) response is predominantly to IgG2a (30, 31);
similar early IgG2a production has been seen in response to
other viruses (32). In contrast, switching in the response to
NP-CGG and similar hapten–protein conjugates is mainly
to IgG1 (33–35). In this study the stage of lymphocyte acti-
vation is compared with the relative amounts of C
 
g
 
1 and
C
 
g
 
2a switch transcript and IL-4 and IFN-
 
g
 
 mRNA produced
in lymph nodes during the responses to MMTV(SW) and
NP-CGG. The findings confirm the earlier observation
that Th2 cytokine profiles are established at an early stage
during immune responses to protein antigens (36–38). This
study indicates that Th1 and Th2 cytokine profiles start to
be established during T cell priming and that immunoglob-
ulin class switching starts when virgin B cells that have
taken up antigen make cognate interaction with primed T
cells in the outer T zone.
 
Materials and Methods
 
Mice and Immunizations.
 
BALB/c mice were purchased from
HO Harlan OLAC Ltd. (Bicester, UK) and kept in isolators un-
der sterile conditions. Immunogens NP-CGG and MMTV(SW)
were prepared as described elsewhere (26). Adult mice (6-12 wk)
were injected into one hind footpad with MMTV(SW) (
 
z
 
10
 
8
 
 vi-
rus particles) and into the other hind footpad with 25 
 
m
 
g alum-
precipitated NP-CGG with or without 5 
 
3 
 
10
 
8
 
 chemically killed
 
Bordetella pertussis
 
 (Evans Medical, Liverpool, UK) or 
 
B. pertussis
 
alone. Mice received 5-bromo-2
 
9
 
-deoxyuridine (BrdU) 2 h be-
fore killing as described (26).
 
Tissue Preparation.
 
Mice were killed by CO
 
2
 
 asphyxiation and
draining popliteal lymph nodes and spleens were removed. The
lymph nodes were put on aluminum foil in a defined orientation,
embedded in OCT compound (Miles Inc., Kankakee, IL), and
frozen by sequential dipping in liquid N
 
2
 
. Spleens were put on
aluminum foil and snap-frozen by sequential dipping in liquid
N
 
2
 
. Tissues were stored in sealed polythene bags at –70
 
8
 
C until
use. 5-
 
m
 
m cryostat sections of the tissue were mounted on four-
spot glass slides for immunohistology. After cutting the first eight
sections, which were used for immunohistology, one 5-
 
m
 
m sec-
tion of spleen or three 24-
 
m
 
m sections of lymph node were cut,
placed in a polypropylene microfuge tube, and stored at –70
 
8
 
C
 
for mRNA extraction. The glass-mounted sections were air dried
for 1 h and then fixed in acetone at 4
 
8
 
C for 20 min. They were
again dried for 10 min before sealing in polythene bags and were
stored at –20
 
8
 
C until used.
 
Immunohistological Staining.
 
Immunohistological reagents and
staining was as described earlier (26). Tissue sections were triple
stained for CD3 with IgD and BrdU, double stained for MHC II
or syndecan-1 together with BrdU, or double stained for NP-
specific cells together with IgM, IgG1, or IgG2a. Additional anti-
bodies used were rat mAbs anti-IgM (LO-MM-9), anti-IgG1
(LO-MG1-2), and anti-IgG2a (LO-MG2a-3; all from Serotec
Ltd., Kidlington, Oxford, UK). The primary rat antibodies were
detected using biotinylated rabbit anti–rat Ig (Dako Ltd., High
Wycombe, UK). NP-binding cells were detected with NP con-
jugated to sheep anti–human IL-2 IgG (The Binding Site, Bir-
mingham, UK). This antiserum does not react unspecifically with
cells of unimmunized mouse lymph nodes (see Fig. 5) or lymph
nodes immunized with an unrelated antigen (data not shown).
Sheep IgG was detected using biotinylated rabbit anti–goat Ig
(Dako Ltd.).
The number of T cells proliferating in the T zone was assessed
from sections that were double stained for Ia and BrdU. The Ia
staining identifies both interdigitating dendritic cells and B cells.
BrdU
 
1
 
 nuclei not surrounded by Ia were taken to be proliferating
T cells. The location of the T zone was determined on an adja-
cent section stained for CD3 and IgD; this section could not be
used to count proliferating T cells as BrdU
 
1
 
 B cells in the T zone
surrounded by CD3
 
1
 
 cells can not be identified as being CD3
 
–
 
cells. Proliferation of plasmablasts and plasma cells was assessed af-
ter double staining for syndecan-1 and BrdU and counting the
numbers of BrdU-positive and -negative cells expressing synde-
can-1. Switched B cells and plasma cells were identified as cells
with cytoplasmic IgG1 or IgG2a in sections double stained with
anti-IgG1 or anti-IgG2a and anti-IgD. Switching in NP-specific
cells was determined by double staining with NP-conjugated
sheep IgG and anti-IgM, anti-IgG1, or anti-IgG2a and counting
IgM-, IgG1-, or IgG2a-positive and NP-binding cells. Germinal
center sizes were determined on sections triple stained for CD3,
IgD and BrdU and measuring of IgD
 
2
 
 areas within the IgD
 
1
 
 fol-
licles as described in Toellner et al. (24).
 
Semiquantitative Reverse Transcriptase–PCR.
 
Lymph node sec-
tions were allocated random numbers before cDNA preparation
and PCR to avoid systematic errors or bias. cDNA from tissues
was prepared as previously described (24). cDNAs were diluted to
100 
 
m
 
l with H
 
2
 
O and stored at 4
 
8
 
C. Mouse 
 
b
 
-actin–specific
primer sequences were obtained from Stratagene (Cambridge,
UK). IL-4– and IFN-
 
g
 
–specific primers were as described by
Svetic et al. (37). Other intron-spanning primers were designed
using OLIGO version 5.0 (National Biosciences, Plymouth,
MA). C
 
g
 
1 switch transcript-specific primers were (CCTCCTA-
GACAAGCACAGGCATGTAGA) and (ACCATGGAGTTA-
GTTTGGGCAGCAG)
 
 
 
specific for the first exon of C
 
g
 
1 switch
transcript and the first exon of C
 
g
 
1 constant region (these data are
available from GenBank/EMBL/DDBJ under accession numbers
M12389 and J00453). Primers specific for C
 
g
 
2a switch transcript
were (GTGCCTACCTGCAGCCTGGGAT) located in exon 1
upstream of the first splice site of the C
 
g
 
2a switch transcript (39)
and (CACTGACCACCCGGAGAGTACTGTTG) located in
the C
 
g
 
2a constant region (these data are available from Gen-
Bank/EMBL/DDBJ under accession number J00470). Primers
were synthesized by Life Technologies (Paisley, UK).
To quantitate cDNAs by Southern blot analysis, 
 
z
 
10 fewer
cycles than would be required to detect the PCR product using
 
1
 
Abbreviations used in this paper: 
 
BrdU, 5-bromo-2
 
9
 
-deoxyuridine; CGG,
chicken 
 
g 
 
globulin; MMTV(SW), Swiss type mouse mammary tumor vi-
rus; NP, (4-hydroxy-3-nitrophenyl)acetyl.
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ethidium bromide gels were done, this was determined in prelim-
inary experiments. For each cDNA sample three amplifications at
different cycle numbers were made to improve precision and
check that amplification was logarithmic in the range of cycle
numbers used. PCR was performed with 2 
 
m
 
l cDNA template in
20 
 
m
 
l vol. For amplification of 
 
b
 
-actin and C
 
g
 
1 switch transcript
0.1 
 
m
 
l Taq-Polymerase (Promega Corp., Madison, WI) per reac-
tion was mixed with TaqStart antibody (CLONTECH Laborato-
ries, Inc., Palo Alto, CA) 1:1 5 min before use. All other cDNAs
were amplified using 0.1 
 
m
 
l AmpliTaq Gold (Perkin Elmer, Lan-
gen, Germany) per reaction. Buffers were used as supplied with
the enzymes, plus 1 
 
m
 
M of each primer, 200 
 
m
 
M of each dNTP
and 2.0 mM MgCl
 
2
 
 for C
 
g
 
1 switch transcript, 2.75 mM MgCl
 
2
 
for C
 
g
 
2a switch transcript, or 1.5 mM MgCl
 
2
 
 for the other cDNAs.
The reaction mix was overlaid with one drop of mineral oil
(Sigma Chemical Co., Poole, England). The three PCRs were
performed in 0.2-ml 96-well polypropylene plates in the three
blocks of a Touch Down thermal cycler (Hybaid, Middlesex,
UK). Cycling was done with an initial denaturation step of 2 min
for Taq-Polymerase or 9 min for AmpliTaq Gold, followed by 30 s
at 94
 
8
 
C, 30 s at annealing temperature (60
 
8
 
C for 
 
b
 
-actin, 65
 
8
 
C
for switch transcripts, and 50
 
8
 
C for cytokine mRNA) and 2 min
plus 2 s for every cycle at 72
 
8
 
C (3 min for C
 
g
 
2a switch tran-
script). Cycle numbers were 16 
 
6
 
 2 for 
 
b
 
-actin, 24 
 
6
 
 2 for both
switch transcript, 28
 
 6
 
 2 for IL-4 mRNA and 31
 
 6
 
 2 for IFN-
 
g
 
mRNA. The PCR product was separated on a 1.5% agarose gel
and transferred onto a prewetted Hybond-N
 
1
 
 membrane (Am-
ersham International, Little Chalfont, UK) by capillary transfer
under alkaline conditions (40). The membrane was hybridized
with a 
 
32
 
P-labeled purified PCR product from an earlier PCR as
a probe as described earlier (24) and imaged using a PhosphorIm-
ager (Molecular Dynamics, Kent, UK).
Using the ImageQuant software (Molecular Dynamics) a grid
was laid over the PCR bands, with individual fields covering the
central 50% of a band. The signal in each field was calculated and
these figures transferred to a spreadsheet software to sort the ran-
domized figures to the correct order. The average of the three
PCRs with different cycle number for each gene was taken and
divided by the average of the three corresponding 
 
b
 
-actin PCRs.
These values are equivalent to the relative amount of mRNA for
a gene per cell. This was multiplied with the section area, deter-
mined by microscopy on adjacent sections using the point count-
ing technique (41), to give the mRNA amount per section.
PCR specific for 
 
b
 
-actin, C
 
g
 
1 switch transcript, IL-4, and
IFN-
 
g
 
 mRNA resulted in single bands and PCR for C
 
g
 
2a switch
transcript in three bands of the expected size (39). Identity of the
PCR products was confirmed by DNA sequencing (Alta Bio-
sciences, Birmingham, UK), using the PCR primers as sequenc-
ing primers. The data were controlled for any signs of saturation
of the PCR reaction between different cycle numbers. This was
done by plotting PCR data from the three PCRs for a particular
gene and checking for variations in the efficiency of the PCR
amplification over different cycle numbers in samples containing
a high amount of target cDNA with samples having low content
of target cDNA. The amplification was shown to be logarithmic
within the range of cycle numbers used.
Figure 1. Photomicrographs
showing the extrafollicular plasma
cells in the response to NP-CGG
with or without B. pertussis. (A)
A typical popliteal lymph node
from a nonimmunized, isolator
bred, and maintained specific
pathogen-free mouse. There are
no germinal centers, minimal T
zone proliferation, and only oc-
casional plasma cells (arrowed) are
seen in the undeveloped medul-
lary cords: F, primary follicles; T,
T zone; M, medulla. (B) Section
of a mouse popliteal lymph node
8 d after immunization with NP-
CGG plus B. pertussis. Well-devel-
oped medullary cords are present,
which are filled with syndecan1
plasma cells (blue). The red nu-
clear staining marks cells that
have taken up BrdU given in the
2 h before the node was taken:
FM, follicular mantle; G, germi-
nal center. (C and D) Sections
through medullary cords stained
to show NP-binding in blue and
IgG2a in gold; (C) from a node
8 d after immunization with NP-
CGG only; NP-specific plasma
cells are present but no IgG2a1
cells are seen; (D) from a node
8 d after immunization with NP-
CGG with B. pertussis; NP-spe-
cific cells and non–NP-specific IgG2a1 plasma cells are seen; one IgG2a1 NP-specific cell is stained dark brown (arrowed). Quantitative data correspond-
ing to the cells shown in C and D are given in Table 1. Bars: (A and B) 100 mm; (C and D) 50 mm.
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Results
T Cell Priming Begins on the Third Day After Immuniza-
tion. The background level of T and B cell proliferation
in popliteal lymph nodes from the isolator bred and main-
tained mice studied was low (Figs. 1 A and 2). The onset of
T cell priming in the popliteal lymph node response to
footpad injection with MMTV(SW) or NP-CGG was as-
sessed by the time when T cell proliferation was first noted
in the T zone. The data shown in Fig. 2 confirm our previ-
ously published observation (26) that in the response to
MMTV(SW) and to alum-precipitated NP-CGG given
with B. pertussis T cell proliferation starts during the third
day after immunization. In that paper flow cytometry stud-
ies of lymph node cells in the response to MMTV showed
some 60,000 CD41 T cells in cell cycle per lymph node on
day 3 and twice this on day 5. After this there was a dra-
matic fall in the number of proliferating cells. In the NP-
CGG response 20,000 CD41 T cells were in cell cycle on
day 3 and 60,000 on day 5. After this T cell proliferation
stopped in the T zone but some continued in germinal
centers. This switch from T zone to follicular T cell prolif-
eration, which coincides with the onset of antibody pro-
duction, is documented in detail in Gulbranson-Judge et al.
(42). In the absence of B. pertussis the start of the T cell re-
sponse to NP-CGG was more variable (Fig. 2); strong T
cell proliferation was present in 2 out of 5 animals after 3 d,
it was well established in all animals by 5 d.
Plasma Cell Production and Immunoglobulin Class Switching.
Very few plasma cells or plasmablasts (Figs. 1 A and 3)
were present in the popliteal lymph nodes of nonimmu-
nized control mice. In all responses local plasma cell pro-
duction was associated with exponential growth of anti-
gen-specific B blasts in the medullary cords. These blasts
were most apparent 5 d after immunization (Fig. 3); at this
Figure 2. The onset and extent of T cell proliferation in the T zone re-
sponse to MMTV(SW), alum-precipitated NP-CGG with B. pertussis,
and alum-precipitated NP-CGG alone. Number of T cells in the T zone
are shown that had taken up BrdU during a 2-h pulse before the lymph
node was taken. Each point shown represents the value for one mouse.
Three of the five mice immunized with alum-precipitated NP-CGG
alone 3 d earlier showed T zone T cell proliferation levels that were at or
near background levels. The values for these three mice in this and subse-
quent figures are shown in open squares (u). Mice were given an i.p. in-
jection of 1 mg BrdU 2 h before the lymph nodes were taken. Cell iden-
tification and the counting procedures are described in Materials and
Methods. The lines are drawn through the median values at each time point.
Figure 3. The onset and extent of B cell proliferation and plasma cell formation in response to MMTV(SW), alum-precipitated NP-CGG with B. per-
tussis, and alum-precipitated NP-CGG alone. The upper panels show the number of plasmablasts (syndecan-11, BrdU1 cells) in the medullary cords. The
lower panels show the number of plasma cells (syndecan-11, BrdU2 cells) in the medullary cords. Each square shown represents the value for one mouse.
Mice were given an i.p. injection of 1 mg BrdU 2 h before the lymph nodes were taken. Cell identification and the counting procedures are described in
Materials and Methods. The lines are drawn through the median values at each time point.
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stage the commitment of B cells to differentiation to
plasma cells was already apparent by their expression of
syndecan-1 and specific IgM and IgG antibody is detectable
in the serum (26). By 8 d many of these cells had come out
of cell cycle and had become fully differentiated plasma
cells, which filled the distended medullary cords (Fig. 1 
 
B
 
).
Again the response in animals immunized with protein
without adjuvant was slightly delayed (Fig. 3).
The response to MMTV(SW) is associated with a bias to
IgG2a production with four to fives times more IgG2a than
IgG1 plasma cells (Fig. 4). In the response to NP-CGG
alone switching was almost exclusively to IgG1 (Fig. 4).
When 
 
B. pertussis
 
 was added to NP-CGG the amount of
IgG1 increased and substantial numbers of IgG2a were pro-
duced (Fig. 4). Control immunizations with 
 
B. pertussis
 
alone showed relatively little IgG1 production, but num-
bers of IgG2a plasma cells equivalent to those seen in mice
immunized with NP-CGG with 
 
B. pertussis
 
 (Fig. 4).
Whereas 23–60% of the NP-specific cells were IgG1
 
1
 
 on d 5
of the response to NP-CGG with 
 
B. pertussis
 
, only 0.2–
1.8% of the NP-specific cells had switched to IgG2a (Table
1). By day 8 the respective ranges were 80–95% for IgG1
and 0.4–10.6% for IgG2a (Fig. 1, 
 
C
 
 and 
 
D
 
). Thus, factors
inducing non–NP-specific plasma cells to switch to IgG2a
were only affecting small numbers of the NP-specific cells
activated in the same node.
In the response to NP-CGG, antigen-specific B cells and
plasma cells were detected and the relative numbers of IgG
and IgM NP-specific plasma cells were assessed (Fig. 5). By
day 5 up to 40% of the cells containing NP-specific anti-
body had switched in the responses to NP-CGG with or
without 
 
B. pertussis
 
. There was a further increase in the
number of switched NP-specific plasma cells with 95% of
these being switched in the response with 
 
B. pertussis.
Switch Transcript Production, Like T Cell Proliferation, Starts
During the Third Day After Immunization.
 
Semiquantitative
values for the amount of C
 
g
 
1 switch transcript and C
 
g
 
2a
produced in mouse popliteal lymph nodes at intervals after
Figure 4. The number of IgG1 and IgG2a containing cells in lymph nodes from mice immunized with: MMTV(SW), alum-precipitated NP-CGG
with B. pertussis and alum-precipitated NP-CGG alone. The lines are drawn through the median values at each time point. Open circles (s) show the re-
sponse to B. pertussis alone.
 
Table 1.
 
Ig Class Switching in NP-specific Plasma Cells
 
Day after
NP-CGG
 
1
 
B. pertussis
 
Total number of plasma
cells and percentage of
these expressing different
Ig isotypes
Number of NP-specific
plasma cells and
percentage of these
expressing different
Ig isotypes
number
 
m
 
1
 
g
 
1
 
1
 
g
 
2a
 
1
 
number
 
m
 
1
 
g
 
1
 
1
 
g
 
2a
 
1
 
5 3210 26% 45% 30% 328 75% 23% 1.8%
5 1078 34% 59% 7% 157 61% 38% 0.6%
5 5057 45% 18% 37% 270 59% 40% 0.7%
5 4755 30% 61% 9% 968 40% 60% 0.2%
8 2796 9% 86% 6% 525 6% 93% 0.4%
8 7920 11% 76% 14% 1,397 9% 87% 3.5%
8 3060 8% 85% 7% 500 4% 95% 1.2%
8 6645 12% 58% 31% 1,118 10% 80% 10.6%
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immunization are shown in Fig. 6. Switch transcripts were
already easily detectable 3 d after primary immunization
and correspond to the immunoglobulin isotype profile of
plasmablasts that are seen two days later (Fig. 4). At this
stage, in the response to NP-CGG plus B. pertussis, NP-
specific B cells were identifiable in the T zone. These
amounted to ,10 cells per section (Fig. 5). The number of
nonswitched NP-specific cells increased z50-fold over the
next 2 d through exponential growth in the medullary
cords. This growth is reflected in the appearance and in-
crease in proliferating syndecan1 cells. These increase some
20-fold between day 3 and 5 in the response to NP-CGG
with B. pertussis (Fig. 3 and reference 26). Importantly the
level of Cg1 or Cg2a switch transcripts less than doubles
over that period (Fig. 6), indicating that the main produc-
tion of switch transcripts is at the time of cognate B cell T
cell interaction as opposed to the period of B cell growth in
the medullary cords. Three of the five mice given alum-
precipitated NP-CGG without B. pertussis did not show T
cell proliferation 72 h after immunization; Cg1 switch
transcript in these mice was at background levels. On the
other hand, in the two mice where T cell proliferation in
the T zone had started switch transcript production was ap-
parent. A consistent finding is that switch transcript levels
only rise above background levels in nodes where T cell
proliferation has already started. Equally no mice were
found where T cell proliferation had started in the absence
of detectable switch transcript levels. These two processes
evidently start well within 24 h of each other.
mRNA for Cytokines Associated with Class Switching Is
Upregulated as T Cells Start to Proliferate. IL-4 message was
upregulated from the day T cell proliferation was first
noted in nodes draining the site of immunization with
alum-precipitated NP-CGG with or without B. pertussis
(Fig. 7). By contrast IL-4 message increased later and to a
lesser extent in the nodes draining the site of MMTV(SW)
injection. This correlated with relatively modest produc-
tion of Cg1 switch transcript in this response.
The upregulation of IFN-g message was less impressive
than that for IL-4. Nevertheless significant elevation of
IFN-g message occurred in the responses associated with
switching to IgG2a, MMTV(SW) and NP-CGG with B.
pertussis. By contrast in the response to NP-CGG alone
where IgG2a plasma cells did not appear IFN-g message
levels remained in the control range. The time of upregula-
tion of cytokine message is sufficiently early in the response
to be consistent with the concept that Ig class switching is
induced by cognate T cell interaction in the T zone and is
influenced by the production of these cytokines at that
stage.
Germinal Center Formation. Developing germinal cen-
ters were identifiable by day 5 in the NP-CGG responses
but their development was delayed by some days in the
MMTV(SW) response (Fig. 8). In all groups the germinal
center size at d 16 was similar to or greater than that at d 8.
The onset of switch transcript production antedates germi-
nal center formation and the time when centrocytes are se-
lected in germinal centers. Nevertheless the persistence of
switch transcripts through day 16 suggests that there is con-
tinued switching in germinal centers.
Control Immunizations. Footpad immunization with B.
pertussis alone induced Cg2a switch transcripts (Fig. 6) and
IFN-g mRNA (Fig. 7) at the times and levels comparable
to those induced by immunization with NP-CGG plus B.
pertussis. Mice immunized with B. pertussis alone showed
some increase in Cg1 switch transcript levels and IL-4
Figure 5. The number of NP-specific
IgM1 and IgG1 cells produced in re-
sponse to alum-precipitated NP-CGG
given with (left) or without B. pertussis.
The lines are drawn through the median
values at each time point.
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Figure 6. Differential induction of Cg1 and Cg2a switch transcript in groups of mice immunized with alum-precipitated NP-CGG with or without
B. pertussis or MMTV(SW). Symbols show the amount of switch transcript per lymph node section of individual mice determined by semiquantitative re-
verse transcriptase–PCR (see Materials and Methods). Three of the five mice immunized with alum-precipitated NP-CGG alone 3 d earlier showed T
zone T cell proliferation levels that were at or near background levels, the values for these mice are shown in open squares (u) as in Fig. 2. Open circles
(s) show the response to B. pertussis alone. Lines are drawn through the median values at each time point.
Figure 7. Differential induction of IL-4 and IFN-g mRNA in groups of mice immunized with alum-precipitated NP-CGG with or without B. pertus-
sis or MMTV(SW). Amount of cytokine mRNA per lymph node section determined by semiquantitative reverse transcriptase–PCR. Open squares (u)
indicate mice which had not shown T cell proliferation on day 3 (Fig. 2). Open circles (s) show the response to B. pertussis alone. The lines are drawn
through the median values at each time point.
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mRNA levels on d 5, but no significant increase above
background of either of these on d 3 (Fig. 6 and 7).
Spleens taken 3 and 5 d after footpad immunization with
MMTV(SW) and NP-CGG with B. pertussis were analyzed
for NP-specific cells, switch transcripts, and cytokine
mRNA. NP-specific cells B cell numbers in the spleen did
not increase above the extremely low levels seen in nonim-
munized mice and were also not found in the popliteal
lymph node draining the site of MMTV(SW) injection
(data not shown). Levels of Cg1 and Cg2a switch transcript
and IFN-g and IL-4 message from the d 3 and 5 spleens of
these isolator reared mice remained in the range seen in
nonimmunized mice (data not shown).
Discussion
Early Commitment to Th1 and Th2 Patterns of Response.
The time when the Th1 and Th2 cytokine profiles, respec-
tively, start to develop in response to MMTV(SW) and
NP-CGG has been determined by assessing the time when
IL-4 and IFN-g message increases in primary immune re-
sponses. This occurs during the third day after immuniza-
tion when T cells first start to proliferate in association with
interdigitating dendritic cells (26). Cognate interaction be-
tween T and B cells leading to B cell growth and the pro-
duction of switch transcripts occurs on the same day, pre-
sumably shortly after the onset of T cell priming. The
functional significance of the switch transcripts observed is
indicated by the development of switched plasmablasts by
day 5 after immunization. In the response to NP-CGG it is
theoretically possible that T cell priming started before the
onset of a detectable increase in T cell proliferation. This
could apply if the number of antigen-reactive T cells ini-
tially was very low. This reservation does not apply to the
response to MMTV(SW) where 10% of T cells are super-
antigen-reactive through their expression of Vb6 (26). The
availability of so many antigen-specific T cells allows the
timing of the onset of the priming process to be predicted
with confidence.
The different switch transcript and cytokine profiles that
appear during the responses to MMTV(SW), NP-CGG
with B. pertussis and NP-CGG alone indicate that Th1 and
Th2 characteristics start to develop as T cells are primed or
very shortly after this. These observations indicate that Th1
or Th2 characteristics can be exhibited by cells that have
not gone through an uncommitted Th0 phase of prolifera-
tion with the production of both IL-4 and IFN-g (43, 44).
The Th cells functioning early in the primary response may
undergo subsequent alteration, but as the Th1 and Th2 cy-
tokines are self-reinforcing (44) the initial pattern is likely
to have an important impact on the way a response be-
comes established.
Studies of the primary responses in lymph nodes to KLH
have reported the early development of Th2 cells. Upregu-
lation of IL-4 mRNA was noted on the third day after im-
munization and IL-4 producing cells could be cultured
from this time (36, 37). In a recent study, Nakamura et al.
(45) reported that naïve T cells cultured with Con A ini-
tially upregulate both IFN-g and IL-4 message, but when
IL-4 is present in the culture the IL-4 message was selec-
tively retained while the IFN-g message is lost within 48 h.
The converse is the case when IL-12 is added to cultures.
The move to IL-4 production has been associated with
continued expression of the transcription factor GATA-3
while this is not expressed in Th1 cells (46). It would be of
interest to assess the expression of this transcription factor
in T cells proliferating in the T zone on the third day of the
test responses analyzed in this study.
The early differentiation of Th1 and Th2 characteristics
raises the possibility that this behavior initially is established
by signals delivered by the interdigitating dendritic cells in
the T zone and that their precursor Langerhans cells in turn
acquire the ability to deliver these signals in the site where
they are induced to take up and process antigen. Thus, tis-
sue Langerhans cells are induced to take up and process an-
tigen following local tissue injury (47); LPS, IL-1, and
TNF-a induce this behavior and the migration of the acti-
vated cells to lymphoid tissues (48, 49). The perturbation
that leads to the activation of Langerhans cells may also in-
duce local cytokine production that influences the way dif-
ferentiation to interdigitating dendritic cells occurs. Mast
cells may release IL-4 after mechanical disruption or C3a-
Figure 8. The development and size of germinal centers during primary responses to: MMTV(SW), alum-precipitated NP-CGG with B. pertussis, and
alum-precipitated NP-CGG alone. Germinal centers were identified in sections triple stained for IgD, CD3, and BrdU. Germinal centers are IgD2 areas
surrounded by IgD1 follicular mantle B cells and contain proliferating BrdU1 cells and only scattered T cells. The lines are drawn through the median
values at each time point.
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or IgE-induced degranulation, CGG might have induced
complement fixation and IFN-g may be released by a
range of cells including NK cells.
De Smedt et al. (50) found that interdigitating dendritic
cells induced to differentiate from Langerhans cells in the
presence of IL-10 failed to prime T cells to differentiate
into Th2 cells. Differential CD80 and CD86 induction during
Langerhans cell maturation has been described under the
influence of Th1 and Th2 cytokines (51). Both CD80 and
CD86 were found to be upregulated in the presence of IL-4;
CD80 was seen to be downregulated by IL-10 or IFN-g and
CD86 expression reduced by IL-10 but not IFN-g. The level
of IL-12 produced and released by IDC may also be influ-
enced by the conditions of Langerhans cell activation (52).
Cells other than interdigitating dendritic cells that might
influence the very early differentiation of Th cells in pri-
mary responses include bystander CD4 or CD8 T cells, NK
cells, NK1.1 T cells, B cells, macrophages, or mast cells. In
the response to Leishmania major Vb4Va8-expressing CD4
T cells produce large amounts of IL-4 within 90 min of in-
jection of LACK protein or after infection in susceptible
but not resistant mice (53). Staphylococcal enterotoxin super-
antigens have been found to activate CD8 T cells express-
ing the appropriate Vb despite the association of the super-
antigen with MHC class II molecules (54, 55). This
stimulation would be likely to induce IFN-g release, but in
MMTV(SW) infection the superantigen has not been seen
to activate Vb6-expressing CD8 T cells (28, 29).
The finding that B. pertussis induces a substantial level of
switching to IgG2a without markedly deviating the over-
whelming IgG1 predominance of the response to NP-
CGG suggests that bystander effects were, at best, small in
this study. This observation may reflect a very short range
effect of cytokines. Cytokines have been shown to be pref-
erentially released at the site of contact between T and B
cells during cognate interactions. In this situation there is
likely to be a highly selective influence on the cell that is
recognized specifically (56, 57). It will be important in fu-
ture studies to attempt to visualize cytokine protein pro-
duction and release in vivo in relation to cognate T cell B
cell interactions. Although this is possible in intact cell con-
jugates formed in vitro it remains a technical challenge to
reproduce these studies consistently in tissue sections.
NK1.1 T cell (58, 59) and NK cell (60) activity in lymph
nodes is generally low, but even rare cells could have a
marked effect locally. Mast cells in lymph nodes are gener-
ally confined to the medulla. In this study no direct infor-
mation about the cells that are producing cytokine message
is available. Although this is a technically difficult area of
investigation, information is required about the cytokines
that are produced in the series of microenvironments that
provide the theater for immune responses: (a) the site of
immunization, (b) the T zone during T cell priming, (c) at
the edge of the T zone during cognate interaction between
T and B cells, and (d) in follicles and extrafollicular sites of
exponential B cell growth and differentiation.
Class Switching During Primary Cognate Interaction between
T Cells and B Cells. When the numbers of antigen-spe-
cific B cells found in lymph node sections are compared to
the amount of switch transcript in adjacent sections, it is
seen that Cg switch transcript levels per cell are greatest
while B cells undergo their first cognate interaction with T
cells in the T zone on day 3 after immunization. This cor-
relates with findings from studies in vitro, where signals
from T cells like CD40 ligation on B cells can induce Ig
class switching efficiently (15, 61). It is also similar to find-
ings in secondary immune responses, where the highest
amount of switch transcript per antigen-specific B cell is
found during the first cognate interaction in the T zone
(24). Switching during cognate interaction in the T zone
inevitably has a major impact on the Ig classes and sub-
classes produced during a primary or secondary immune
response because these B cells subsequently undergo expo-
nential growth both within and outside follicles (24, 62, 63).
Ig class switching has also been shown to occur in germi-
nal centers (25). Continued switch transcript production at
16 d in the primary responses reported here is likely to be
occurring as centrocytes are selected in germinal centers
(25). There is also less switch transcript found on day 16 in
the MMTV(SW) response where germinal centers are
much smaller and the increase of switching to IgG1 in this
response occurs as germinal centers are formed. Although
the number of antigen-specific cells in germinal centers at
day 16 is much greater than the number present in the
lymph nodes 3 d after immunization, the amount of switch
transcript recovered at these two times is comparable. B
cells of human tonsil undergoing T–B interaction in the T
zone have not been isolated and there is no information
about whether they undergo switch recombination (25).
The impact of switching in centrocytes may be lower, as B
cells that have been positively selected in germinal centers
are only likely to undergo further proliferation if they are
reactivated by antigen.
Ig class switching has also been reported to occur in sites
of inflammation. This is exemplified by switching to IgE in
the nasal mucosa in patients with allergic rhinitis (64).
Switching to IgE is likely to be a secondary switching event
after previous switch to IgG1 (6–8).
In a previous study of the primary splenic response to in-
traperitoneal NP-CGG (24), markedly lower levels of
switch transcript production were detected per unit
amount of b-actin than in the primary lymph node re-
sponse. This may reflect in part a higher proportion of cells
involved with class switching in lymph nodes, which lack
the large red pulp component of the spleen. Ig class switch-
ing in the spleen is occurring later after primary immuniza-
tion with NP-CGG (63) than in lymph nodes. The slower
rate of T cell priming that occurs in the spleen (65) com-
pared to lymph nodes (66) may be associated with a lower
number of cognate T cell B cell interactions occurring at
any one time.
It is perhaps surprising that there is little change in the
level of switch transcript production between days 3, 5, and
8 after immunization, for there is massive exponential
growth of B cells in the medullary cords and follicles dur-
ing this period and Ig class switching has been associated to
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B cell proliferation (10, 67, 68). New antigen-specific vir-
gin B cells are likely to continue to arrive in the node for
several days after immunization. Some of these will be de-
rived from recirculating cells arriving from distant lym-
phoid tissues (69) and others will be newly produced virgin
B cells (70). These cells are likely to make cognate interac-
tion with primed T cells in the node draining the site of
immunization. The rate of these cognate interactions might
be expected to be relatively constant in the first 5 d after
immunization until sufficient amounts of antibody are pro-
duced to bind free antigen. Most of the switching observed
during this period may be occurring in B cells during these
cognate interactions rather than in their proliferating prog-
eny. This tentative conclusion suggests that the dual signals
provided by CD40 ligation and cytokines are delivered by
the interacting primed T cell. Other cytokines produced by
the responding B cells and adjacent interdigitating dendritic
cells may also contribute, but cytokine influence during the
subsequent growth phase of the B cells may have a rela-
tively small effect on Ig class switching.
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